Loading market data...
Thursday, August 6, 2026
All companies
Cigna Group logo

Cigna GroupCI

U.S. LISTEDHealth Carecigna.com

About Cigna Group

The Cigna Group is a health services organization built around two principal businesses. Evernorth Health Services, its largest revenue contributor, houses pharmacy benefit management through Express Scripts, specialty pharmacy, care delivery, and benefits administration sold to health plans, employers, and government programs. Cigna Healthcare provides commercial medical insurance and stop-loss coverage, primarily to U.S. employers ranging from small groups to multinational corporations, along with a smaller international health business serving globally mobile employees and expatriates. While Evernorth generates the majority of top-line revenue given the pass-through nature of pharmaceutical dispensing, Cigna Healthcare's commercial insurance book historically contributes a disproportionate share of operating earnings relative to its revenue footprint.

Investors track medical cost ratios in the commercial book, which govern underwriting profitability and can move sharply with utilization trends. Pharmacy benefit economics draw persistent regulatory and political attention, with periodic legislative proposals targeting rebate practices, spread pricing, and vertical integration between PBMs, insurers, and pharmacies. Customer concentration in Evernorth is a durable question, as a handful of large health plan clients represent meaningful share, and contract renewals with those anchors are watched closely. Capital allocation leans on steady buybacks and a dividend, funded by insurance subsidiary upstreaming subject to state regulator approval. Governance features include a unified board following the Express Scripts combination, and the company sits in large-cap managed care index cohorts.

The company traces to Connecticut General Life Insurance, founded in 1865, and INA Corporation, whose Insurance Company of North America dated to 1792. CIGNA was formed by their 1982 merger and progressively pivoted from property-casualty toward health and employee benefits, divesting individual life and P&C lines over subsequent decades. The transformative step came in 2018, when Cigna acquired Express Scripts, then the largest standalone pharmacy benefit manager in the United States, reorganizing the health services businesses under the Evernorth brand in 2020. In 2022 Cigna divested its international life, accident, and supplemental benefits business to Chubb, and in 2024 sold its Medicare Advantage and related businesses to Health Care Service Corporation, sharpening the current two-segment structure.

Revenue reaches Cigna through several channels with distinct economics. Employers, unions, and government payers contract with Express Scripts for pharmacy benefit administration, with fees, rebate retention, and pharmacy network spread forming the earnings mix; specialty pharmacy dispensing of high-cost drugs is a significant component. In Cigna Healthcare, self-funded employer clients pay administrative service fees while Cigna bears clinical management and, under stop-loss, tail claims risk; fully insured commercial and international customers pay premiums against which medical claims are underwritten. Competitive position rests on scale in pharmacy purchasing, integrated clinical programs, and national provider networks, positioning it against UnitedHealth, CVS Health, Elevance, and Humana. Revenue is overwhelmingly domestic.

Company profile by LineVest editorial. Journalism, not investment advice. Commission a full SEC-based report on Cigna Group

Cigna Group coverage

No Cigna Group stories yet — LineVest publishes U.S. market news daily, and new coverage of Cigna Group will appear here automatically.

Browse the latest U.S. market news →

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on Cigna Group

We read Cigna Group's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Cigna Group report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.